Related Experiment Videos
[Malignant catatonia].
M de Entrambasaguas1, J L Sánchez, W Schonewille
1Servicio de Neurología y Neurofisiología, Clínica Rotger, Palma de Mallorca, España.
Revista De Neurologia
|March 24, 2000
Summary
Malignant catatonia, a severe syndrome potentially linked to decreased dopamine activity, can be effectively treated with early electroconvulsive therapy (ECT). This case highlights successful remission in a patient with idiopathic malignant catatonia.
Area of Science:
- Neurology
- Psychiatry
Background:
- Malignant catatonia is associated with significantly reduced central dopaminergic activity.
- Potential etiologies include medical, psychiatric, toxic-pharmacologic, or idiopathic origins.
Observation:
- A 24-year-old male presented with seizures, progressing to severe catatonia, agitation, and paranoid ideation.
- The patient developed aspiration pneumonia, requiring Intensive Care Unit (ICU) admission and prolonged management.
- Diagnostic workup, including neuroimaging and laboratory tests, did not yield an etiological diagnosis.
Findings:
- Electroencephalogram (EEG) initially showed focal, then generalized, theta and delta waves.
- The patient received 27 sessions of electroconvulsive therapy (ECT) over three months, leading to remission of catatonic symptoms.
- Final diagnosis was idiopathic malignant catatonia, with residual amnesia upon discharge.
Implications:
- Management of malignant catatonia can be complex due to diverse etiologies and potential lethality.
- Early initiation of electroconvulsive therapy (ECT) is crucial for favorable outcomes.
- Successful treatment is contingent on the treatability of the underlying cause and absence of central nervous system structural lesions.